Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.757860
Title: Modelling normal tissue toxicity in pancreatic chemoradiotherapy
Author: Witztum, Alon
ISNI:       0000 0004 7430 6694
Awarding Body: University of Oxford
Current Institution: University of Oxford
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
The relationship between radiation dose and toxicity in pancreatic chemoradiotherapy is not well understood. Clinically, excessive normal tissue toxicity is avoided by placing a constraint on the volume of the organ receiving a dose above a threshold. Dose-volume constraints lack spatial information which may be important in determining normal tissue response. Spatial dose distribution information can be found in dose-surface maps (DSMs). A dose-surface map is a 2-dimensional virtual unwrapping of the surface dose of on organ. Due to the complex geometry of the duodenum, previous methods for unwrapping tubular organs for spatial toxicity modelling are insuficient. A geometrically robust method for producing dose-surface maps, specifically for the duodenum, was created in order to characterise the spatial dose distribution. This unwrapping methodology was shown to be generalisable to simple organs such as the stomach, and extendable to more complex organs such as the bronchial tree. A graphical user interface to create dose-surface maps from organs in commercial treatment planning systems was also demonstrated. Duodenal and stomach dose-surface maps were created for patients from two pancreatic chemoradiotherapy trials, ARCII and SCALOP, treating locally-advanced pancreatic cancer (LAPC). New spatial features were extracted from dose-surface maps and their correlation with upper-gastrointestinal toxicity quantified and compared to traditional dose-volume metrics. The predictive power of some of these new metrics were found to be superior to dose-volume metrics in the stomach, but no significant correlation was found in the duodenum. Duodenal motion throughout treatment occurs both due to respiratory motion and peristalsis. On board imaging using cone-beam CT (CBCT) during individual treatment fractions shows that interfraction variability is non-systematic and cannot be predicted. While abdominal compression is able to restrict some interfraction motion, it is unable to control peristaltic changes. Accumulated duodenal dose-surface maps from these images were created to investigate the differences between the planned and delivered dose.
Supervisor: Hawkins, Maria ; Van den Heuvel, Frank ; George, Ben Sponsor: Medical Research Council
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.757860  DOI: Not available
Share: